Insider Transactions

What Lexeo Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	7	27
Total trades	11	43

Shares traded

	3 months	12 months
Acquired	146,060	546,936
Disposed	66,326	168,601
Net activity	+79,734	+378,335

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Townsend Richard Nolan	Chief Executive Officer	Aug 18	Open-market sale · S	−3,345	$4.95	−$16.6K	374,472
Otero Jose Manuel	Chief Operating Officer	Aug 18	Open-market sale · S	−1,304	$4.96	−$6.46K	136,178
Tamayo Louis Edward	Chief Financial Officer	Aug 18	Open-market sale · S	−4,117	$4.91	−$20.2K	92,907
Townsend Richard Nolan	Chief Executive Officer	Jul 01	Open-market sale · S	−25,947	$4.48	−$116K	377,817
Otero Jose Manuel	Chief Operating Officer	Jul 01	Open-market sale · S	−4,666	$4.48	−$20.9K	137,482
Tamayo Louis Edward	Chief Financial Officer	Jul 01	Open-market sale · S	−4,641	$4.49	−$20.8K	97,024
Bhalla Narinder Pal	Chief Medical Officer	Jul 01	Open-market sale · S	−22,306	$4.42	−$98.6K	82,194
Townsend Richard Nolan	Chief Executive Officer	Jun 29	Grant / award · A	+67,000	—	—	403,764
Otero Jose Manuel	Chief Operating Officer	Jun 29	Grant / award · A	+12,060	—	—	142,148
Tamayo Louis Edward	Chief Financial Officer	Jun 29	Grant / award · A	+12,000	—	—	101,665
Bhalla Narinder Pal	Chief Medical Officer	Jun 29	Grant / award · A	+55,000	—	—	104,500
Townsend Richard Nolan	Chief Executive Officer	May 18	Open-market sale · S	−3,342	$5.06	−$16.9K	336,764
Otero Jose Manuel	Chief Operating Officer	May 18	Open-market sale · S	−1,302	$5.07	−$6.61K	130,088
Townsend Richard Nolan	Chief Executive Officer	Apr 06	Open-market sale · S	−55,000	$5.69	−$313K	340,106
Townsend Richard Nolan	Chief Executive Officer	Mar 13	Grant / award · A	+2,623	$2.64	+$6.94K	395,106
Otero Jose Manuel	Chief Operating Officer	Mar 13	Grant / award · A	+5,930	$2.64	+$15.7K	131,390
Townsend Richard Nolan	Chief Executive Officer	Feb 18	Open-market sale · S	−10,173	$6.38	−$64.9K	392,483
Otero Jose Manuel	Chief Operating Officer	Feb 18	Open-market sale · S	−3,016	$6.40	−$19.3K	125,460
Bhalla Narinder Pal	Chief Medical Officer	Feb 13	Grant / award · A	+49,500	—	—	49,500
Townsend Richard Nolan	Chief Executive Officer	Feb 04	Grant / award · A	+161,665	—	—	402,656

Page 1 of 6 · showing the 20 most recent Sign up free to view all 102 transactions and filter by insider →